[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Economic Values for Radiation Exposure Reduction
Pertaining to $ per person-rem values, here is some feedback:
1) NCRP Report No. 120, "Dose Control at Nuclear Power Plants,"
devotes considerable discussion to the topic of $ per
person-rem values.
2) (Note: As I was writing this, some messages were coming
through on RadSafe mentioning the NUREG below. I will
leave this in my message, however, because it appeared most
people were "just" saying the NRC $1,000 value was changed to
$2,000 -- It is not quite that simple, as you will see below.)
The NRC recently issued NUREG/BR-0058, Revision 2, entitled
Regulatory Analysis Guidelines of the Nuclear Regulatory
Commission." In the Federal Register Notice announcing
availability of the NUREG on December 20, 1995, the NRC
stated, "The staff's reevaluation has now been completed
and the Commission has decided to implement a $ 2,000 per
person-rem conversion factor, subject it to present worth
considerations, and limit its scope solely to health effects. This
is in contrast to the previous policy and staff practice of using
an undiscounted $ 1,000 per person-rem conversion factor which
served as a surrogate for all offsite consequences (health and
offsite property)." The notice indicates that the net effect of
the revised factor is "mixed." "In most regulatory applications
... The doubling of the conversion factor and the discounting tend
to cancel each other."
3) I prefer not to publish my company's $ per person-rem value on the
Internet, but I will say that ComEd uses a value that correlates
well to the results of a survey performed of other nuclear
utilities. Typical values are 10,000 to 15,000 dollars per
person-rem. The usage of a $ per person-rem value, however, seems
to vary widely. ComEd uses its value strictly for "screening"
purposes to determine the relative merit of a project's potential
contribution to the goal of further reducing radiation exposures.
It must be recognized that the use of a screening value does not
represent actual cash flows. In addition, this screening value is
not intended to have any broader implications such as the value of
life itself, etc.
Kit Weaver
Principal Technical Expert
Nuclear Support
ComEd
tsnkw@ccmail.ceco.com